<DOC>
	<DOCNO>NCT01520233</DOCNO>
	<brief_summary>RATIONALE : Studying sample tumor tissue patient cancer laboratory may help doctor learn change occur RNA predict patient respond treatment . It may also help doctor find good way treat cancer . PURPOSE : This research trial study gene expression predict outcome samples patient high-risk neuroblastoma .</brief_summary>
	<brief_title>Gene Expression Predicting Outcome Samples From Patients With High-Risk Neuroblastoma</brief_title>
	<detailed_description>OBJECTIVES : - To test correlation previously publish microarray gene expression signature gene expression obtain nCounter™ Analysis System use RNA isolate formalin-fixed , paraffin-embedded ( FFPE ) , high-risk neuroblastoma sample . - To construct , test , validate novel robust classifier readily integrate clinic . OUTLINE : This multicenter study . RNA sample extract paraffin-embedded tissue analyze gene signature expression level nCounter™ Analysis System correlate publish microarray expression data . Results use develop refined gene-expression-profile classifier ultra high-risk neuroblastoma .</detailed_description>
	<mesh_term>Neuroblastoma</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Formalinfixed paraffinembedded tumor section link clinical outcome data collect highrisk neuroblastoma patient ( n=100 ) treat University Chicago , St. Jude Children 's Research Hospital , Children 's Memorial Hospital , Texas Children 's Hospital PATIENT CHARACTERISTICS : Not specify PRIOR CONCURRENT THERAPY : Not specify</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>disseminate neuroblastoma</keyword>
	<keyword>localize unresectable neuroblastoma</keyword>
	<keyword>recurrent neuroblastoma</keyword>
	<keyword>regional neuroblastoma</keyword>
	<keyword>stage 4S neuroblastoma</keyword>
</DOC>